Tislelizumab With Fruquintinib, Metronidazole, in Mismatch Repair-proficient or Microsatellite Stability, Advanced Colorectal Cancer: a Multicenter, Single Arm, Clinical Trial
Conditions: Colorectal Cancer Interventions: Drug: Tislelizumab with Fruquintinib, Metronidazole Sponsors: Jing-yuan Fang, MD, Ph. D Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

Screen-and-treat Strategy for Vaginal Flora Abnormalities in Pregnant Women at High Risk of Preterm Birth
Conditions: Bacterial Vaginosis; Vaginal Dysbiosis; Premature Delivery Interventions: Diagnostic Test: Vaginal flora abnormalities screening and quantification using molecular biology technique; Drug: Azithromycine; Drug: Ceftriaxone; Drug: Metronidazole; Drug: Clotrimazole, Vaginal; Other: Usual Care Sponsors: Assistance Publique Hopitaux De Marseille Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials

Comparisons Of Different Antiplaque Agents On Gingivitis In Orthodontic Patients
Conditions: Gingivitis Interventions: Drug: Chlorhexidine Gluconate; Drug: Metronidazole; Drug: combination gel (chlorhexidine and metronidazole); Drug: Placebo Sponsors: Anam Sattar Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials

Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole
Conditions: Trichomonas Vaginitis Interventions: Drug: Metronidazole 500 mg; Drug: Secnidazole 2000 MG Sponsors: Tulane University; University of Alabama at Birmingham; Louisiana State University Health Sciences Center in New Orleans Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials

Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection
Conditions: Helicobacter Pylori Infection Interventions: Drug: Bismuth Subcitrate; Drug: Esomeprazole; Drug: Metronidazole; Drug: Amoxicillin; Drug: Clarithromycin; Drug: Levofloxacin Sponsors: National Institute of Public Health, Slovenia; Community Healthcare Center dr. Adolf Drolc Maribor (HCM) Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials

Amoxicillin and Metronidazole During or After the Periodontal Treatment
Conditions: Periodontitis Interventions: Procedure: Scaling and root planing; Drug: Placebos during SRP; Drug: Placebos after SRP; Drug: Metronidazole during SRP; Drug: Amoxicillin during SRP; Drug: Metronidazole after SRP; Drug: Amoxicillin after SRP Sponsors: Bel én Retamal-Valdes Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials

Fourteen-Day Vonoprazan-Based Dual Therapy With Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy
Conditions: Helicobacter Pylori Infection Interventions: Drug: Vonoprazan and Amoxicillin; Drug: Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole Sponsors: Fu Jen Catholic University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials

A prospective, single-centre, randomized, double-blind controlled study protocol to study whether long-term oral metronidazole can effectively reduce the incidence of postoperative liver metastasis in patients with colorectal cancer
This study is a prospective, single-centre, randomized, double-blind controlled study in which 300 patients will be randomly assigned to the test group or the control group in a 1:1 allocation ratio. The aim of this trial is to demonstrate that long-term oral antibiotics can effectively reduce the incidence of postoperative liver metastasis in patients with colorectal cancer.Ethics and disseminationEthics approval was obtained from the Ethics Committee at the Chinese Ethics Committee of Registering Clinical Trials (ChiECRCT20210229). The results of this study will be disseminated at several research conferences and as publ...
Source: Trials - December 4, 2023 Category: Research Source Type: clinical trials

Evaluation of L-PRF as an Antibiotic Slow-release Biological Device in the Treatment of Moderate Periodontitis
Conditions: Periodontitis Interventions: Drug: Subgingival application of L-PRF loaded with metronidazole; Other: Subgingival application of L-PRF Sponsors: Yasmeen Khaled Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials

Vaginal lIve Biotherapeutic RANdomized Trial
Conditions: Bacterial Vaginosis Interventions: Drug: LC106; Drug: LC115; Drug: Placebo; Drug: Metronidazole Oral Sponsors: Massachusetts General Hospital; Bill and Melinda Gates Foundation; Ragon Institute of MGH, MIT and Harvard; Centre for the AIDS Programme of Research in South Africa Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials

Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice
Conditions: Periodontitis; Periodontal Diseases; Periodontal Pocket Interventions: Drug: Amoxicillin; Drug: Metronidazole; Other: Placebo Sponsors: Rutgers, The State University of New Jersey; National Institute of Dental and Craniofacial Research (NIDCR); National Dental PBRN Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials

Combination Study of Antibiotics With Enzalutamide (PROMIZE)
Conditions: Metastatic Castration-Resistant Prostate Cancer (mCRPC) Interventions: Drug: Enzalutamide 40mg; Drug: Amoxicillin 500mg; Drug: Metronidazole 400mg; Drug: Vancomycin 125mg; Drug: Ciprofloxacin 500g Sponsors: Institute of Cancer Research, United Kingdom; Prostate Cancer Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials

Comparing the Efficacy of Metronidazole and Minocycline Gels for the Treatment of Diabetic Periodontitis Patients
Conditions:   Periodontitis;   Diabetes Mellitus Interventions:   Drug: 1ml of 1% metronidazole gel;   Drug: 1ml of 2% minocycline gel;   Drug: 1ml of combination of 1% metronidazole gel and 2% minocycline Sponsor:   Riphah International University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials